Adalimumab for Ocular Inflammation

PURPOSE: To evaluate adalimumab as an immunomodulatory treatment for non-infectious ocular inflammatory diseases. METHODS: Characteristics of patients treated with adalimumab were abstracted in a standardized chart review. Main outcomes measured were control of inflammation, corticosteroid-sparing e...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ocul Immunol Inflamm
Hlavní autoři: Durrani, Khayyam, Kempen, John H., Ying, Gui-shuang, Kacmaz, R. Oktay, Artornsombudh, Pichaporn, Rosenbaum, James T., Suhler, Eric B., Thorne, Jennifer E., Jabs, Douglas A., Levy-Clarke, Grace A., Nussenblatt, Robert B., Foster, C. Stephen
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5033708/
https://ncbi.nlm.nih.gov/pubmed/27003323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/09273948.2015.1134581
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky